NYSEARCA:CNY

Market Vectors Chinese Renminbi/USD ETN Stock Forecast, Price & News

$44.25
0.00 (0.00 %)
(As of 03/30/2020)
Add
Compare
Today's Range
$43.50
$44.25
50-Day Range
$44.25
$44.25
52-Week Range
$40.00
$47.00
Volume292 shs
Average Volume1,121 shs
Market Capitalization$7.83 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CNY News and Ratings via Email

Sign-up to receive the latest news and ratings for Market Vectors Chinese Renminbi/USD ETN and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Van Eck
Fund NameVanEck Vectors Renminbi/USD ETN
Tax ClassificationExchange-Traded Note
SymbolNYSEARCA:CNY
Inception Date3/14/2008
Fund Manager
WebN/A
PhoneN/A

Fund Focus

Asset ClassCurrency
BenchmarkS&P Chinese Renminbi Total Return Index
CategoryChinese Renminbi
FocusChinese Renminbi
Development LevelEmerging Markets
RegionAsia-Pacific

Fund Statistics

Assets Under Management$7,743.00
Average Daily Volume$48.70
Discount/Premium6.91%

ETF Expenses

Management Fee0.00%
Other Expenses0.00%
Total Expenses0.00%
Fee Waiver0.00%
Net Expenses0.55%

Administrator, Advisor and Custodian

Administrator
Advisor
Custodian
Distributor
Transfer Agent
Trustee
Lead Market MakerSusquehanna

speech bubbles
speech bubbles











Market Vectors Chinese Renminbi/USD ETN (NYSEARCA:CNY) Frequently Asked Questions

What stocks does MarketBeat like better than Market Vectors Chinese Renminbi/USD ETN?

Wall Street analysts have given Market Vectors Chinese Renminbi/USD ETN a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Market Vectors Chinese Renminbi/USD ETN wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Market Vectors Chinese Renminbi/USD ETN's stock been impacted by COVID-19 (Coronavirus)?

Market Vectors Chinese Renminbi/USD ETN's stock was trading at $43.86 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CNY shares have increased by 0.9% and is now trading at $44.25.
View which stocks have been most impacted by COVID-19
.

Who are some of Market Vectors Chinese Renminbi/USD ETN's key competitors?

What other stocks do shareholders of Market Vectors Chinese Renminbi/USD ETN own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Market Vectors Chinese Renminbi/USD ETN investors own include Amarin (AMRN), Aduro Biotech (ADRO), (ALT), Armata Pharmaceuticals (ARMP), CRISPR Therapeutics (CRSP), Nabriva Therapeutics (NBRV), Occidental Petroleum (OXY), VBI Vaccines (VBIV), Vaxart (VXRT) and Aethlon Medical (AEMD).

What is Market Vectors Chinese Renminbi/USD ETN's stock symbol?

Market Vectors Chinese Renminbi/USD ETN trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "CNY."

How do I buy shares of Market Vectors Chinese Renminbi/USD ETN?

Shares of CNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Market Vectors Chinese Renminbi/USD ETN's stock price today?

One share of CNY stock can currently be purchased for approximately $44.25.

How much money does Market Vectors Chinese Renminbi/USD ETN make?

Market Vectors Chinese Renminbi/USD ETN has a market capitalization of $7.83 million.


This page was last updated on 9/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.